CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity - PubMed (original) (raw)
. 2003 Apr 15;101(8):3052-7.
doi: 10.1182/blood-2002-09-2876. Epub 2002 Dec 12.
Affiliations
- PMID: 12480696
- DOI: 10.1182/blood-2002-09-2876
Free article
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity
Todd A Fehniger et al. Blood. 2003.
Free article
Abstract
Natural killer (NK) cells are innate lymphocytes that provide cytokines critical for early host defense against pathogens. One subset of human NK cells (CD56(bright)) constitutively expresses the high-affinity interleukin 2 (IL-2) receptor and produces immunoregulatory cytokines. Here, we demonstrate that CD56(bright) NK cells are present in human lymph nodes and that endogenous T cell-derived IL-2, acting through the NK high-affinity IL-2 receptor, costimulates CD56(bright) NK cells to secrete IFN-gamma. Thus, adaptive immunoregulators influence innate cytokine production, which in turn may influence the developing antigen-specific immune response. These data show a dynamic interaction between innate and adaptive human lymphocytes and emphasize the importance of studying interactions between immune components to understand the immune response as a whole.
Similar articles
- Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Cooper MA, et al. Blood. 2001 May 15;97(10):3146-51. doi: 10.1182/blood.v97.10.3146. Blood. 2001. PMID: 11342442 - Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
Cooper MA, Fehniger TA, Ponnappan A, Mehta V, Wewers MD, Caligiuri MA. Cooper MA, et al. Eur J Immunol. 2001 Mar;31(3):792-801. doi: 10.1002/1521-4141(200103)31:3<792::aid-immu792>3.0.co;2-u. Eur J Immunol. 2001. PMID: 11241284 - Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. Carson WE, et al. J Exp Med. 1994 Oct 1;180(4):1395-403. doi: 10.1084/jem.180.4.1395. J Exp Med. 1994. PMID: 7523571 Free PMC article. - The biology of human natural killer-cell subsets.
Cooper MA, Fehniger TA, Caligiuri MA. Cooper MA, et al. Trends Immunol. 2001 Nov;22(11):633-40. doi: 10.1016/s1471-4906(01)02060-9. Trends Immunol. 2001. PMID: 11698225 Review. - The Role of Natural Killer Cells in Autoimmune Diseases.
Kucuksezer UC, Aktas Cetin E, Esen F, Tahrali I, Akdeniz N, Gelmez MY, Deniz G. Kucuksezer UC, et al. Front Immunol. 2021 Feb 25;12:622306. doi: 10.3389/fimmu.2021.622306. eCollection 2021. Front Immunol. 2021. PMID: 33717125 Free PMC article. Review.
Cited by
- Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme.
Cooksey LC, Friesen DC, Mangan ED, Mathew PA. Cooksey LC, et al. Cells. 2024 Sep 17;13(18):1567. doi: 10.3390/cells13181567. Cells. 2024. PMID: 39329751 Free PMC article. Review. - The basic biology of NK cells and its application in tumor immunotherapy.
Jiang P, Jing S, Sheng G, Jia F. Jiang P, et al. Front Immunol. 2024 Aug 16;15:1420205. doi: 10.3389/fimmu.2024.1420205. eCollection 2024. Front Immunol. 2024. PMID: 39221244 Free PMC article. Review. - NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity.
Graham LV, Khakoo SI, Blunt MD. Graham LV, et al. Biomedicines. 2024 Jul 25;12(8):1667. doi: 10.3390/biomedicines12081667. Biomedicines. 2024. PMID: 39200132 Free PMC article. Review. - Immune surveillance of cytomegalovirus in tissues.
Mihalić A, Železnjak J, Lisnić B, Jonjić S, Juranić Lisnić V, Brizić I. Mihalić A, et al. Cell Mol Immunol. 2024 Sep;21(9):959-981. doi: 10.1038/s41423-024-01186-2. Epub 2024 Aug 12. Cell Mol Immunol. 2024. PMID: 39134803 Free PMC article. Review. - Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity.
Sanz-Ortega L, Leijonhufvud C, Schoutens L, Lambert M, Levy E, Andersson A, Wahlin BE, Carlsten M. Sanz-Ortega L, et al. NPJ Precis Oncol. 2024 May 20;8(1):108. doi: 10.1038/s41698-024-00595-w. NPJ Precis Oncol. 2024. PMID: 38769377 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials